» Authors » Igor Piotrowski

Igor Piotrowski

Explore the profile of Igor Piotrowski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 271
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Szewczyk M, Ostapowicz J, Piotrowski I, Ostrowska K, Suchorska W, Golusinski W
Contemp Oncol (Pozn) . 2025 Feb; 28(4):291-296. PMID: 39935755
Introduction: Despite advances in diagnostics and therapy, the 5-year mortality rate of oral squamous cell cancer (OSCC) remains at about 50%. Prognostic molecular biomarkers are not yet approved for clinical...
2.
Matuszak N, Piotrowski I, Kruszyna-Mochalska M, Skrobala A, Mocydlarz-Adamcewicz M, Malicki J
Rep Pract Oncol Radiother . 2025 Jan; 29(5):638-648. PMID: 39759550
Background: The biological effects and clinical consequences of out-of-field radiation in peripheral organs can be difficult to determine, especially for low doses (0.1 Gy-1 Gy). In recent years, Monte Carlo...
3.
Stepka J, Dotka M, Kosinski M, Suchecki P, Hobot M, Piotrowski I
Cureus . 2024 Oct; 16(9):e70532. PMID: 39439623
The primary treatment for gliomas typically involves tumor resection followed by adjuvant radiotherapy, with increasing emphasis on chemotherapy and molecularly targeted drugs. This study aimed to review and summarize the...
4.
Musielak M, Bakun P, Liwarska J, Skupin-Mrugalska P, Piotrowski I, Suchorska W
Adv Med Sci . 2024 Jul; 69(2):331-338. PMID: 39025260
Purpose: Breast cancer is a complex disease with several molecular subtypes that respond differently to therapy. This paper describes liposomes loaded with gold nanoparticles as a targeted drug delivery method...
5.
Piwocka O, Piotrowski I, Suchorska W, Kulcenty K
Front Mol Biosci . 2024 Mar; 11:1343523. PMID: 38455762
The tumor microenvironment (TME) is a complex ecosystem of cells, signaling molecules, and extracellular matrix components that profoundly influence cancer progression. Among the key players in the TME, cancer-associated fibroblasts...
6.
Piwocka O, Musielak M, Ampula K, Piotrowski I, Adamczyk B, Fundowicz M, et al.
Cancer Cell Int . 2024 Jan; 24(1):28. PMID: 38212739
Primary cell lines are invaluable for exploring cancer biology and investigating novel treatments. Despite their numerous advantages, primary cultures are laborious to obtain and maintain in culture. Hence, established cell...
7.
Ostrowska K, Niewinski P, Piotrowski I, Ostapowicz J, Koczot S, Suchorska W, et al.
Clin Transl Oncol . 2024 Jan; 26(4):1022-1032. PMID: 38175424
Background: Cellular senescence is a state characterized by cell-cycle arrest and apoptotic resistance. Senescence in cancer may be induced by oncogenes or therapy. While cellular senescence might play an important...
8.
Piwocka O, Musielak M, Piotrowski I, Kulcenty K, Adamczyk B, Fundowicz M, et al.
Rep Pract Oncol Radiother . 2023 Jul; 28(2):159-171. PMID: 37456709
Background: Cancer-associated fibroblasts (CAFs) are a diverse subset of cells, that is recently gaining in popularity and have the potential to become a new target for breast cancer (BC) therapy;...
9.
Wroblewska J, Lach M, Rucinski M, Piotrowski I, Galus L, Suchorska W, et al.
Front Cell Dev Biol . 2023 Jan; 10:1008901. PMID: 36619870
Uveal melanoma (UM) is a rare type of malignancy that originates from melanocytes in the choroid, iris and the eye's ciliary body. Biomarkers for early detection and progression of UM,...
10.
Musielak M, Piwocka O, Kulcenty K, Ampula K, Adamczyk B, Piotrowski I, et al.
Am J Cancer Res . 2022 Oct; 12(9):4411-4427. PMID: 36225645
Cancer-associated fibroblasts are a highly heterogeneous group of cells whose phenotypes and gene alterations are still under deep investigation. As a part of tumor microenvironment, they are the focus of...